X Trademark

Trademark Overview


On Wednesday, May 10, 2023, a trademark application was filed for X with the United States Patent and Trademark Office. The USPTO has given the X trademark a serial number of 97930249. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, April 4, 2024. This trademark is owned by 23andMe, Inc.. The X trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of anxiety, depression, insomnia, sexual dysfunction, seasonal affective disorder, birth control, hair loss, acne, urinary tract infections, cold sores, herpes, asthma, acid reflux, high blood pressure, hot flashes, migraines, skin dark spots, hypothyroidism, smoking, sinus infections, blood cholesterol, sexually transmitted diseases; pharmaceutical preparations in the nature of blood tests for blood sugar, blood cholesterol, and blood type

Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies
x

General Information


Serial Number97930249
Word MarkX
Filing DateWednesday, May 10, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, April 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Description of MarkThe mark consists of a pair of shaded rectangles with rounded corners that appear crossed to form a stylized chromosome design in the shape of a lopsided and stylized "X".
Goods and ServicesPrescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of anxiety, depression, insomnia, sexual dysfunction, seasonal affective disorder, birth control, hair loss, acne, urinary tract infections, cold sores, herpes, asthma, acid reflux, high blood pressure, hot flashes, migraines, skin dark spots, hypothyroidism, smoking, sinus infections, blood cholesterol, sexually transmitted diseases; pharmaceutical preparations in the nature of blood tests for blood sugar, blood cholesterol, and blood type
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, June 9, 2023
Primary Code035
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History


Party Name23andMe, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94086

Trademark Events


Event DateEvent Description
Thursday, April 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2024EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2024EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, February 22, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 22, 2024ASSIGNED TO LIE
Wednesday, February 21, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 21, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, February 21, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, February 2, 2024ASSIGNED TO EXAMINER
Saturday, June 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 13, 2023NEW APPLICATION ENTERED